Wound dressing
Latest Bristol-Myers Squibb Company Patents:
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Method of purity determination by capillary electrophoresis
- Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
- ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
- Supramolecular filamentous assemblies for protein purification
Description
The FIGURE is a plan view of a wound dressing, showing our new design.
The undisclosed sides form no part of the claimed design.
Claims
We claim the ornamental design for a wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D480144
Type: Grant
Filed: Dec 20, 2002
Date of Patent: Sep 30, 2003
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Simon Adams (Holywell), Stephen Bishop (Hawarden), Bryan Griffiths (Upton), Helen Shaw (Widnes)
Primary Examiner: Stella Reid
Attorney, Agent or Law Firm: John M. Kilcoyne
Application Number: 29/173,068
Type: Grant
Filed: Dec 20, 2002
Date of Patent: Sep 30, 2003
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Simon Adams (Holywell), Stephen Bishop (Hawarden), Bryan Griffiths (Upton), Helen Shaw (Widnes)
Primary Examiner: Stella Reid
Attorney, Agent or Law Firm: John M. Kilcoyne
Application Number: 29/173,068
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)
International Classification: 2404;
International Classification: 2404;
